Hims & Hers Health (NYSE: HIMS)
Hims & Hers Health Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Hims & Hers Health Company Info
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
News & Analysis
2 No-Brainer Growth Stocks to Buy Right Now
Big News! U.S. and China Trade Deal Shakes Up Markets
Stocks are soaring today on the hope that the trade tensions between the U.S. and China are behind us.
Massive Hims & Hers News: $1 Billion on AI and Acquisitions
Hims & Hers is getting $1 billion of rocket fuel.
Hims & Hers Has a Superpower in Healthcare
This isn't just any growth stock.
Hims & Hers Health Shocks Investors With a Long-Term Forecast, but Is the Stock a Buy?
Why Is Hims & Hers Stock Skyrocketing?
Hims & Hers Jumps 18.2% on Incredible 111% Revenue Growth
Hims & Hers is on fire right now.
Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped
Good news for Hims & Hers stock spooks Lilly and Novo investors.
Valuation
Podcast Episodes
Digesting Super Bowl Ads, Dunkin' & Starbucks Plans, and Some Weight Loss Drug News
The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime.
A New Name in Weight Loss Drugs
Novo Nordisk and Eli Lilly have soared on the popularity of GLP-1 weight loss drugs. Now Hims & Hers is trying to get in on the action with a more available and affordable option.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.